Landon Mark B, Rice Madeline Murguia, Varner Michael W, Casey Brian M, Reddy Uma M, Wapner Ronald J, Rouse Dwight J, Biggio Joseph R, Thorp John M, Chien Edward K, Saade George, Peaceman Alan M, Blackwell Sean C, VanDorsten J Peter
Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH
George Washington University Biostatistics Center, Washington, DC.
Diabetes Care. 2015 Mar;38(3):445-52. doi: 10.2337/dc14-2159. Epub 2014 Nov 20.
To evaluate whether treatment of mild gestational diabetes mellitus (GDM) confers sustained offspring health benefits, including a lower frequency of obesity.
Follow-up study of children (ages 5-10) of women enrolled in a multicenter trial of treatment versus no treatment of mild GDM. Height, weight, blood pressure, waist circumference, fasting glucose, fasting insulin, triglycerides, and HDL cholesterol were measured.
Five hundred of 905 eligible offspring (55%) were enrolled. Maternal baseline characteristics were similar between the follow-up treated and untreated groups. The frequencies of BMI ≥95th (20.8% and 22.9%) and 85th (32.6% and 38.6%) percentiles were not significantly different in treated versus untreated offspring (P = 0.69 and P = 0.26). No associations were observed for BMI z score, log waist circumference, log triglycerides, HDL cholesterol, blood pressure, or log HOMA-estimated insulin resistance (HOMA-IR). The effect of treatment was different by sex for fasting glucose and log HOMA-IR (P for interaction = 0.002 and 0.02, respectively) but not by age-group (5-6 and 7-10 years) for any outcomes. Female offspring of treated women had significantly lower fasting glucose levels.
Although treatment for mild GDM has been associated with neonatal benefits, no reduction in childhood obesity or metabolic dysfunction in the offspring of treated women was found. However, only female offspring of women treated for mild GDM had lower fasting glucose.
评估轻度妊娠期糖尿病(GDM)的治疗是否能为后代带来持续的健康益处,包括降低肥胖发生率。
对参与轻度GDM治疗与未治疗多中心试验的女性所生子女(5 - 10岁)进行随访研究。测量身高、体重、血压、腰围、空腹血糖、空腹胰岛素、甘油三酯和高密度脂蛋白胆固醇。
905名符合条件的后代中有500名(55%)被纳入研究。随访的治疗组和未治疗组之间,母亲的基线特征相似。治疗组与未治疗组后代中BMI≥第95百分位数(20.8%和22.9%)以及第85百分位数(32.6%和38.6%)的频率无显著差异(P = 0.69和P = 0.26)。未观察到BMI z评分、对数腰围、对数甘油三酯、高密度脂蛋白胆固醇、血压或对数稳态模型评估的胰岛素抵抗(HOMA - IR)之间存在关联。对于空腹血糖和对数HOMA - IR,治疗效果因性别而异(交互作用P值分别为0.002和0.02),但对于任何结局,不同年龄组(5 - 6岁和7 - 10岁)之间无差异。接受治疗的女性所生的雌性后代空腹血糖水平显著较低。
尽管轻度GDM的治疗与新生儿益处相关,但未发现治疗女性的后代中儿童肥胖或代谢功能障碍有所减少。然而,仅接受轻度GDM治疗的女性所生的雌性后代空腹血糖较低。